Erin Wilfong, MD, PhD

Vanderbilt University Medical Center
Nashville, Tennessee, United States

As a dual trained rheumatologist and pulmonary-critical care physician, I do translational research in myositis related interstitial lung disease and have a strong clinical interest in life threatening rheumatic disease.

Presentation(s):

• Personalized Treatment for SARD-ILD: Combining Clinical and Biological Features to Inform Management Decisions

  Monday, October 27, 2025
  1:30 PM – 2:00 PM Central Time

  Disclosure(s): Allogene: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Capstan Therapeutics: Consultant (Ongoing); Merck/MSD: Advisor or Review Panel Member (Terminated, September 30, 2024); UpToDate: Royalties (Ongoing)